Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a specific type of breast cancer — either ductal carcinoma in situ or invasive breast cancer — confirmed through a needle biopsy taken before surgery
- People who are already scheduled to have breast-conserving surgery (a procedure that removes the tumour while keeping most of the breast)
- People who are able and willing to sign a written consent form agreeing to take part
Who may not be able to join:
- People whose pre-surgery biopsy showed a non-cancerous (benign) breast condition
- People diagnosed with advanced or spread breast cancer (stage III or IV), or for whom chemotherapy before surgery has been recommended
- People with a cognitive or neurological condition that would make it difficult to understand the study procedures or the consent process
- People who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carlo F Morasso, Ph.D., Istituti Clinici Scientifici Maugeri
Phone: +390382592219
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensitivity and specificity of Spectra-BREAST system margin status prediction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.